Anthracycline-induced cardiomyopathy: cellular and molecular mechanisms.

Clinical Science
Keith DadsonFilio Billia

Abstract

Despite the known risk of cardiotoxicity, anthracyclines are widely prescribed chemotherapeutic agents. They are broadly characterized as being a robust effector of cellular apoptosis in rapidly proliferating cells through its actions in the nucleus and formation of reactive oxygen species (ROS). And, despite the early use of dexrazoxane, no effective treatment strategy has emerged to prevent the development of cardiomyopathy, despite decades of study, suggesting that much more insight into the underlying mechanism of the development of cardiomyopathy is needed. In this review, we detail the specific intracellular activities of anthracyclines, from the cell membrane to the sarcoplasmic reticulum, and highlight potential therapeutic windows that represent the forefront of research into the underlying causes of anthracycline-induced cardiomyopathy.

References

Feb 1, 1974·Annals of Internal Medicine·R H Blum, S K Carter
Oct 15, 1984·FEBS Letters·E J Demant
Aug 1, 1983·Journal of Molecular and Cellular Cardiology·R C Aversano, P J Boor
Oct 1, 1993·Leukemia & Lymphoma·C HershkoA Pinson
Aug 1, 1996·Journal of Molecular and Cellular Cardiology·F LiA M Gerdes
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S M SwainR A Gams
Aug 22, 1997·Biochimica Et Biophysica Acta·C M PalmeiraK B Wallace
Aug 13, 1998·Biophysical Chemistry·K K KarukstisR J Rosenfeld
Sep 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·S M ZemanD M Crothers
Jul 23, 1999·Annals of the New York Academy of Sciences·D KumarP Singal
Jan 29, 2000·Nucleic Acids Research·C CullinaneD R Phillips
Apr 13, 2000·The New England Journal of Medicine·G M FelkerE K Kasper
Aug 22, 2001·Molecular Biology of the Cell·E SmirnovaA M van der Bliek
Aug 2, 2002·Life Sciences·Kazuhiko SaekiTakeshi Matsumoto
Nov 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sanjay AwasthiYogesh C Awasthi
Mar 4, 2003·Nature Reviews. Cancer·Yosef Shiloh
Apr 2, 2003·Circulation·Tetsuo ShioiSeigo Izumo
Jul 29, 2003·Pflügers Archiv : European journal of physiology·Hermann Koepsell, Hitoshi Endou
Oct 29, 2004·Molecular and Cellular Biology·Kevin G McLureMichael B Kastan
May 19, 2005·Cancer Research·Natasha Y FrankMarkus H Frank
May 28, 2005·Circulation Research·Laurent BarandonCécile Duplàa
Jun 21, 2005·Biochemical and Biophysical Research Communications·Mitsunori OkabeTakaaki Abe
Jul 23, 2005·IUBMB Life·Suzanne M CuttsDon R Phillips
May 3, 2006·Cancer Research·Lonnie P SwiftSuzanne M Cutts
Oct 13, 2006·British Journal of Pharmacology·H KaiserováA Bast
Feb 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cameron K TebbiCindy L Schwartz
May 29, 2007·Biochemical and Biophysical Research Communications·Sahoko IchiharaGaku Ichihara
Jul 27, 2007·Cardiovascular Toxicology·Kendall B Wallace
Sep 18, 2007·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Liudmila V SolovjevaNikolai V Tomilin
Oct 25, 2007·Biochemical Society Transactions·M G Chelu, X H T Wehrens
Nov 17, 2007·Cardiovascular Research·Valentina ParraSergio Lavandero

❮ Previous
Next ❯

Citations

Feb 13, 2021·Oxidative Medicine and Cellular Longevity·Rodrigo CarrascoPaaladinesh Thavendiranathan
Aug 18, 2021·Drug Delivery and Translational Research·Sepideh Nezhadi, Farid Abedin Dorkoosh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Postgraduate Medicine
Ashley SimmonsDavid Meyers
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
Agnes S Kim, Steven R Bergmann
Annals of Oncology : Official Journal of the European Society for Medical Oncology
A C YoungD Dodwell
© 2021 Meta ULC. All rights reserved